Loss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome

Christopher S Ward, Teng-Wei Huang, José A Herrera, Rodney C Samaco, Meagan R Pitcher, Alan Herron, Steven A Skinner, Walter E Kaufmann, Daniel G Glaze, Alan K Percy, Jeffrey L Neul, Christopher S Ward, Teng-Wei Huang, José A Herrera, Rodney C Samaco, Meagan R Pitcher, Alan Herron, Steven A Skinner, Walter E Kaufmann, Daniel G Glaze, Alan K Percy, Jeffrey L Neul

Abstract

Rett Syndrome (RTT) is a neurodevelopmental disorder characterized by loss of acquired skills during development, autonomic dysfunction, and an increased risk for premature lethality. Clinical experience identified a subset of individuals with RTT that present with urological dysfunction including individuals with frequent urinary tract infections, kidney stones, and urine retention requiring frequent catheterization for bladder voiding. To determine if urologic dysfunction is a feature of RTT, we queried the Rett Syndrome Natural History Study, a repository of clinical data from over 1000 individuals with RTT and found multiple instances of urological dysfunction. We then evaluated urological function in a mouse model of RTT and found an abnormal pattern of micturition. Both male and female mice possessing Mecp2 mutations show a decrease in urine output per micturition event. Furthermore, we identified signs of kidney failure secondary to urethral obstruction. Although genetic strain background significantly affects both survival and penetrance of the urethral obstruction phenotype, survival and penetrance of urethral obstruction do not directly correlate. We have identified an additional phenotype caused by loss of MeCP2, urological dysfunction. Furthermore, we urge caution in the interpretation of survival data as an endpoint in preclinical studies, especially where causes of mortality are poorly characterized.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Micturition is impaired by loss…
Fig 1. Micturition is impaired by loss of MeCP2 function.
(A,A’) male Mecp2tm1.1Bird/Y (NULL) and female Mecp2tm1.1Bird/+ (HET) mice showed abnormal micturition patterns with an increase in the number of micturition bouts, (B,B’) despite similar total volume of urine expelled during the test interval. (C,C’) Thus, the average volume voided per bout was decreased in NULL and HET mice relative to their WT littermates. (D,D’) Furthermore the maximum volume voided during the session was also reduced in the NULL and HET mice relative to WT littermates. Male 129B6F1 WT N = 8, NULL = 7; Female 129B6F1 WT = 5, HET = 6. *p<0.05 ANOVA for effect of genotype. ns not significant.
Fig 2. Loss of MeCP2 function contributes…
Fig 2. Loss of MeCP2 function contributes to kidney failure in male Mecp2tm1.1Bird/Y mice.
Moribund NULL mice (mori) exhibited evidence of kidney failure compared to normal serum chemistry values in WT or healthy NULL littermates before they become moribund. Moribund NULL mice exhibited (A) normal Na+, (B) increased K+, (C) increased serum osmolarity, (D) decreased bicarbonate, (E) increased creatinine, and (F) increased blood urea nitrogen levels. (WT N≥17, NULL healthy N≥9, NULL moribund N≥7). *p<0.05 versus all other groups determined by ANOVA with Bonferroni post hoc correction for multiple comparisons.
Fig 3. Representative urological pathology of 129B6F1…
Fig 3. Representative urological pathology of 129B6F1 Mecp2tm1.1Bird/Y mice.
(A-A’) Gross examination of moribund NULL mice revealed severely distended bladders compared to WT littermates. Bladders indicated by black arrows. (B) A plug of seminal coagulum was present within the penile urethra of the moribund NULL mice. (C-C’) Coronal H&E stained sections through the penile urethra showed that this plug occludes the urethra, effectively limiting urine outflow. Occlusion of the urethra is indicated by * in C’. (D-E’) The kidneys exhibited moderate hydronephrosis observable at both the gross level (D-D’), and in coronal H&E stained sections taken through the middle of the kidney (E-E’). Scale bars: A-A’ 1cm, B 5mm, C-C’ 250μm, D-D’ 5mm, E-E’ 2mm.
Fig 4. Strain dependent survival in Mecp2…
Fig 4. Strain dependent survival in Mecp2tm1.1Bird/Y mice and penetrance of urethral obstruction.
(A) Survival plots of male Mecp2tm1.1Bird/Y (NULL) mice show premature lethality across all strains tested. FVB NULL mice died significantly earlier than all strains and 129 NULL mice lived significantly longer than 129B6F1 mice. *p<0.05 versus all other strains, and +p<0.05 versus 129B6F1 and FVB as determined by Tarone-Ware statistics from Kaplan-Meier analysis following Bonferroni post hoc correction for multiple comparisons (15 comparisons). (B) Penetrance of urethral obstruction in male moribund NULL mice varied by strain (p<0.001 determined by Chi-Square) with pure strains showing lower penetrance than isogenic F1 strains. (C) Similarly, penetrance of distended bladder while moribund also varied by strain (p<0.001 determined by Chi-Square) and was lower in the pure strains and highest in the isogenic F1 strains. N for each strain is indicated on the respective graphs. Median survival in days is indicated in the key for panel A.

References

    1. Hagberg B. Rett syndrome: Swedish approach to analysis of prevalence and cause. Brain & development. 1985;7(3):276–80. .
    1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature genetics. 1999;23(2):185–8. 10.1038/13810 .
    1. Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology. 2008;70(16):1313–21. 10.1212/01.wnl.0000291011.54508.aa
    1. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al. Rett syndrome: revised diagnostic criteria and nomenclature. Annals of neurology. 2010;68(6):944–50. 10.1002/ana.22124
    1. McCauley MD, Wang T, Mike E, Herrera J, Beavers DL, Huang TW, et al. Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome. Science translational medicine. 2011;3(113):113ra25 10.1126/scitranslmed.3002982 .
    1. Weese-Mayer DE, Lieske SP, Boothby CM, Kenny AS, Bennett HL, Silvestri JM, et al. Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatric research. 2006;60(4):443–9. 10.1203/01.pdr.0000238302.84552.d0 .
    1. Geerdink N, Rotteveel JJ, Lammens M, Sistermans EA, Heikens GT, Gabreels FJ, et al. MECP2 mutation in a boy with severe neonatal encephalopathy: clinical, neuropathological and molecular findings. Neuropediatrics. 2002;33(1):33–6. 10.1055/s-2002-23598 .
    1. Ogier M, Wang H, Hong E, Wang Q, Greenberg ME, Katz DM. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci. 2007;27(40):10912–7. 10.1523/JNEUROSCI.1869-07.2007 .
    1. Viemari JC, Roux JC, Tryba AK, Saywell V, Burnet H, Pena F, et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci. 2005;25(50):11521–30. 10.1523/JNEUROSCI.4373-05.2005 .
    1. Bissonnette JM, Schaevitz LR, Knopp SJ, Zhou Z. Respiratory phenotypes are distinctly affected in mice with common Rett syndrome mutations MeCP2 T158A and R168X. Neuroscience. 2014;267:166–76. 10.1016/j.neuroscience.2014.02.043
    1. Ward CS, Arvide EM, Huang TW, Yoo J, Noebels JL, Neul JL. MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan. J Neurosci. 2011;31(28):10359–70. 10.1523/JNEUROSCI.0057-11.2011
    1. Clayton-Smith J, Walters S, Hobson E, Burkitt-Wright E, Smith R, Toutain A, et al. Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance. Eur J Hum Genet. 2009;17(4):434–43. 10.1038/ejhg.2008.192
    1. Ransmayr GN, Holliger S, Schletterer K, Heidler H, Deibl M, Poewe W, et al. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology. 2008;70(4):299–303. 10.1212/01.wnl.0000296826.61499.26 .
    1. Wheeler JS, Sax DS, Krane RJ, Siroky MB. Vesico-urethral function in Huntington's chorea. British journal of urology. 1985;57(1):63–6. .
    1. Chicoine B, Sulo S. Rate of urinary retention in adults with down syndrome: a prospective study. J Am Board Fam Med. 2015;28(1):115–7. 10.3122/jabfm.2015.01.140065 .
    1. Fernandes Silva JA, Borges Carrerette F, Damião R. Uroflowmetry in the management of lower urinary tract symptoms of children and adolescents with cerebral palsy. J Pediatr Urol. 2014;10(3):413–7. 10.1016/j.jpurol.2013.07.004 .
    1. Percy AK, Neul JL, Glaze DG, Motil KJ, Skinner SA, Khwaja O, et al. Rett syndrome diagnostic criteria: lessons from the Natural History Study. Annals of neurology. 2010;68(6):951–5. 10.1002/ana.22154
    1. Leary S, Underwood W, Anthony R, Cartner S, Corey D, Grandin T, et al. AVMA guidelines for the euthanasia of animals: 2013 edition. 2013.
    1. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature genetics. 2001;27(3):327–31. 10.1038/85906 .
    1. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature genetics. 2001;27(3):322–6. 10.1038/85899 .
    1. Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315(5815):1143–7. 10.1126/science.1138389 .
    1. Sugino Y, Kanematsu A, Hayashi Y, Haga H, Yoshimura N, Yoshimura K, et al. Voided stain on paper method for analysis of mouse urination. Neurourology and urodynamics. 2008;27(6):548–52. 10.1002/nau.20552 .
    1. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature methods. 2012;9(7):671–5. .
    1. FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Disord. 1990;5(3):195–202. 10.1002/mds.870050303 .
    1. Jotkowitz S. Letter: Urinary retention as complication of levodopa therapy. JAMA. 1976;235(24):2586 .
    1. Fischer CP, Diokno A, Lapides J. The anticholinergic effects of dicyclomine hydrochloride in uninhibited neurogenic bladder dysfunction. J Urol. 1978;120(3):328–9. .
    1. Samaco RC, McGraw CM, Ward CS, Sun Y, Neul JL, Zoghbi HY. Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Human molecular genetics. 2013;22(1):96–109. 10.1093/hmg/dds406
    1. Bissonnette JM, Knopp SJ. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Pediatric research. 2006;59(4 Pt 1):513–8. 10.1203/01.pdr.0000203157.31924.4a
    1. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(2):179–86. 10.1001/jama.298.2.179 .
    1. Mårild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr. 1998;87(5):549–52. .
    1. Klarskov P, Andersen JT, Asmussen CF, Brenøe J, Jensen SK, Jensen IL, et al. Acute urinary retention in women: a prospective study of 18 consecutive cases. Scand J Urol Nephrol. 1987;21(1):29–31. .
    1. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126(7):497–504. .
    1. Lieske JC, Peña de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69(4):760–4. 10.1038/sj.ki.5000150 .
    1. Anígilájé EA, Bitto TT. Prevalence and Predictors of Urinary Tract Infections among Children with Cerebral Palsy in Makurdi, Nigeria. Int J Nephrol. 2013;2013:937268 10.1155/2013/937268
    1. Reid CJ, Borzyskowski M. Lower urinary tract dysfunction in cerebral palsy. Arch Dis Child. 1993;68(6):739–42.
    1. Samijn B, Van Laecke E, Renson C, Hoebeke P, Plasschaert F, Vande Walle J, et al. Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: A systematic review. Neurourol Urodyn. 2016. 10.1002/nau.22982 .
    1. Bilbault H, Haymann JP. Experimental models of renal calcium stones in rodents. World J Nephrol. 2016;5(2):189–94. 10.5527/wjn.v5.i2.189
    1. Yu W, Ackert-Bicknell C, Larigakis JD, MacIver B, Steers WD, Churchill GA, et al. Spontaneous voiding by mice reveals strain-specific lower urinary tract function to be a quantitative genetic trait. Am J Physiol Renal Physiol. 2014;306(11):F1296–307. 10.1152/ajprenal.00074.2014
    1. Wells S, Trower C, Hough TA, Stewart M, Cheeseman MT. Urethral obstruction by seminal coagulum is associated with medetomidine-ketamine anesthesia in male mice on C57BL/6J and mixed genetic backgrounds. Journal of the American Association for Laboratory Animal Science: JAALAS. 2009;48(3):296–9.
    1. Todorova MT, Dangler CA, Drage MG, Sheppard BJ, Fox JG, Seyfried TN. Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Epilepsia. 2003;44(1):25–31. .
    1. Ninomiya H, Inomata T, Ogihara K. Obstructive uropathy and hydronephrosis in male KK-Ay mice: a report of cases. The Journal of veterinary medical science / the Japanese Society of Veterinary Science. 1999;61(1):53–7. .
    1. Kunstyr I, Kupper W, Weisser H, Naumann S, Messow C. Urethral plug—a new secondary male sex characteristic in rat and other rodents. Laboratory animals. 1982;16(2):151–5. .
    1. Sokoloff L, Barile MF. Obstructive genitourinary disease in male STR/IN mice. The American journal of pathology. 1962;41:233–46.
    1. Hong CC, Ediger RD. Self-mutilation of the penis in C57BL/6N mice. Laboratory animals. 1978;12(2):55–7. .
    1. Bendele AM, Carlton WW. Incidence of obstructive uropathy in male B6C3F1 mice on a 24-month carcinogenicity study and its apparent prevention by ochratoxin A. Laboratory animal science. 1986;36(3):282–5. .
    1. Rao CN. Obstructive uropathy in group caged male B6C3F1 mice on a 24-month carcinogenicity study. Laboratory animal science. 1987;37(1):8–9. .
    1. Roux JC, Dura E, Moncla A, Mancini J, Villard L. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. The European journal of neuroscience. 2007;25(7):1915–22. 10.1111/j.1460-9568.2007.05466.x .
    1. Kerr AM, Armstrong DD, Prescott RJ, Doyle D, Kearney DL. Rett syndrome: analysis of deaths in the British survey. European child & adolescent psychiatry. 1997;6 Suppl 1:71–4. .
    1. Buchovecky CM, Turley SD, Brown HM, Kyle SM, McDonald JG, Liu B, et al. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nature genetics. 2013;45(9):1013–20. 10.1038/ng.2714

Source: PubMed

3
Prenumerera